Patients with osteoarthritis (OA) of the knee receiving an investigational chemokine inhibitor showed some improvements in ...

The launch of the GSK ‘Understanding Shingles’ research findings aims to raise awareness and address the lack of knowledge ...

Hindustan Unilever’s Q2 net profit is expected to remain flat at ₹2,670 crore as against ₹2,668 crore, year-on-year (YoY).

In patients with moderate to severe Crohn’s disease, guselkumab showed similar efficacy in both biologic-naive and ...

Progressive pulmonary fibrosis (PPF) is an increasingly recognised condition, defined in 2022 to address the progression of ...

Healthcare decision-makers are facing significant challenges that will intensify in the coming years as they work to address ...

The RespiriNTM project has received funding from the Innovative Health Initiative 2 Joint Undertaking (JU) under grant agreement No 853932. This Joined Undertaking receives support from the European ...

A city off-licence has had its licence suspended for six weeks after the owner was caught twice selling illegal goods.

For many, property investor, developer and car park manager Town Centre Securities will come with too many red flags. It is a ...

Nigeria’s manufacturing sector is under siege. The cruel combination of high energy costs, foreign exchange scarcity, rising ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...